Adam Vogel
Stock Analyst at Craig-Hallum
(4.62)
# 901
Out of 4,693 analysts
38
Total ratings
78.1%
Success rate
39.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintained: Buy | $36 | $27.07 | +33.01% | 9 | Aug 12, 2026 | |
| LBRX LB Pharmaceuticals | Maintained: Buy | $36 → $45 | $47.10 | -4.46% | 5 | Aug 12, 2026 | |
| ATHE Alterity Therapeutics | Initiated Coverage: Buy | $12 | $4.55 | +163.74% | 1 | Aug 11, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $6.02 | +66.11% | 6 | Aug 6, 2026 | |
| PEPG PepGen | Maintained: Buy | $11 | $3.12 | +252.56% | 2 | Aug 6, 2026 | |
| DSGN Design Therapeutics | Maintained: Buy | $22 | $15.14 | +45.31% | 5 | Aug 4, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $40 → $25 | $13.31 | +87.83% | 3 | Jul 28, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $114 → $135 | $135.08 | +0.02% | 6 | Jun 22, 2026 | |
| HIT Health In Tech | Maintained: Buy | n/a | $0.968 | - | 1 | Apr 10, 2026 |
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $36
Current: $27.07
Upside: +33.01%
LB Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $36 → $45
Current: $47.10
Upside: -4.46%
Alterity Therapeutics
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.55
Upside: +163.74%
Aclaris Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $10
Current: $6.02
Upside: +66.11%
PepGen
Aug 6, 2026
Maintained: Buy
Price Target: $11
Current: $3.12
Upside: +252.56%
Design Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $22
Current: $15.14
Upside: +45.31%
MapLight Therapeutics
Jul 28, 2026
Maintained: Buy
Price Target: $40 → $25
Current: $13.31
Upside: +87.83%
Apogee Therapeutics
Jun 22, 2026
Downgraded: Hold
Price Target: $114 → $135
Current: $135.08
Upside: +0.02%
Health In Tech
Apr 10, 2026
Maintained: Buy
Price Target: n/a
Current: $0.968
Upside: -